About: NewcelX Ltd., a biopharmaceutical company, engages in developing transformative stem-cell-derived therapies for Diabetes. The company develops NCEL-101, a cellular therapy product based on enriched pancreatic islet-like clusters for the treatment of Type 1 diabetes and Type 2 insulin dependent diabetes; AstroRx, an off-the-shelf cryopreserved cell therapy product for the treatment of Amyotrophic Lateral Sclerosis and neurodegenerative indications; and Dual Orexin-Receptor Agonist (DOXA), a small molecules platform for the treatment of sleep disorders, Neurodegenerative/ neuroinflammation diseases, and Diabetes Associated Neurological Disorders. It also develops iTOL-102, NCEL-201, NCEL-301, and NCEL-007. NewcelX Ltd. was founded in 2008 and is headquartered in Kloten, Switzerland.
Sector: Healthcare
Industry: Biotechnology
Latest price: $3.30 (+1.54%)
NCELNASDAQNewcelX Ltd.
NewcelX Ltd. share price
NCEL price activity
Last Price
$3.300
Change (24hr)
0.05 USD (1.54%)
Volume
3.14K
Volume (4w avg)
-
Open
$3.30
Day Range
$3.18 - $3.30
Previous Close
$3.25
Last Trade
09 Sep, 4:32 pm GMT+0
Delayed
09 Sep, 4:32 pm GMT+0
NCEL price performance
Delayed
09 Sep, 4:32 pm GMT+0
NCEL Market Signals